Intratumoral oncolytic adenoviral treatment modulates the glioma microenvironment and facilitates systemic tumor-antigen-specific T cell therapy.
about
A Comparative Study of Replication-Incompetent and -Competent Adenoviral Therapy-Mediated Immune Response in a Murine Glioma Model.Preclinical Evaluation of Sequential Combination of Oncolytic Adenovirus Delta-24-RGD and Phosphatidylserine-Targeting Antibody in Pancreatic Ductal Adenocarcinoma.Immunotherapeutic Potential of Oncolytic H-1 Parvovirus: Hints of Glioblastoma Microenvironment Conversion towards Immunogenicity.Interleukin 8 activity influences the efficacy of adenoviral oncolytic immunotherapy in cancer patients.Tumor Microenvironment in Treatment of Glioma.
P2860
Intratumoral oncolytic adenoviral treatment modulates the glioma microenvironment and facilitates systemic tumor-antigen-specific T cell therapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Intratumoral oncolytic adenovi ...... tigen-specific T cell therapy.
@en
type
label
Intratumoral oncolytic adenovi ...... tigen-specific T cell therapy.
@en
prefLabel
Intratumoral oncolytic adenovi ...... tigen-specific T cell therapy.
@en
P2093
P2860
P1433
P1476
Intratumoral oncolytic adenovi ...... ntigen-specific T cell therapy
@en
P2093
Alan L Chang
Dirk M Nettlebeck
Jason Miska
Julius W Kim
Maciej S Lesniak
P2860
P304
P356
10.1080/2162402X.2015.1022302
P577
2015-04-02T00:00:00Z